SEC Tracker
Get the app

Halozyme Therapeutics HALO

Torley Helen (President, CEO, Director) plans to sell 150,000 HALO shares, about $11.2M

Form
144
Filed
Importance
Routine
  1. Approximate sale date: Feb 3, 2026
  2. Broker: J.P. Morgan Securities LLC
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Mar 21, 2025

All of Torley Helen's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 2,551 shares at $74.88 on Feb 3, 2026 · Form 4
  • Sold 9,659 shares at $75.94 on Feb 3, 2026 · Form 4
  • Sold 7,790 shares at $76.73 on Feb 3, 2026 · Form 4
  • Sold 9,900 shares at $76.94 on Feb 4, 2026 · Form 4
  • Sold 10,100 shares at $77.54 on Feb 4, 2026 · Form 4
  • Sold 5,376 shares at $78.38 on Feb 5, 2026 · Form 4
  • Sold 4,624 shares at $78.94 on Feb 5, 2026 · Form 4
  • Sold 4,100 shares at $69.2 on Mar 2, 2026 · Form 4
  • Sold 15,322 shares at $69.8 on Mar 2, 2026 · Form 4
  • Sold 578 shares at $70.46 on Mar 2, 2026 · Form 4
  • Sold 13,481 shares at $68.85 on Mar 3, 2026 · Form 4
  • Sold 6,519 shares at $69.33 on Mar 3, 2026 · Form 4
  • Sold 7,329 shares at $69.94 on Mar 4, 2026 · Form 4
  • Sold 2,671 shares at $70.95 on Mar 4, 2026 · Form 4
  • Sold 19,000 shares at $65.36 on Apr 1, 2026 · Form 4
  • Sold 1,000 shares at $65.71 on Apr 1, 2026 · Form 4
  • Sold 15,800 shares at $64.06 on Apr 2, 2026 · Form 4
  • Sold 4,200 shares at $64.89 on Apr 2, 2026 · Form 4
  • Sold 5,900 shares at $63.14 on Apr 6, 2026 · Form 4
  • Sold 4,100 shares at $64.02 on Apr 6, 2026 · Form 4

Written from the Form 144 on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Halozyme Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Axsome Therapeutics AXSM public float $4.4B, Jun 30, 2025
  2. Alkermes ALKS public float $4.7B, Jun 30, 2025
  3. Lantheus Holdings LNTH public float $4.3B, Jun 30, 2025
  4. Adma Biologics ADMA public float $4.2B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.